Hosted on MSN11d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from ...
GlobalData on MSN10d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
UK scientists creating 'cancer vaccine' that may stop killer disease 20 years early
Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...
pharmaphorum11d
GSK backs £50m Oxford University cancer vaccine programme
The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...
Everything we know about Oxford University's 'cancer vaccine' programme
Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...
PharmiWeb11d
GSK and Oxford establish the GSK-Oxford Cancer Immuno-Prevention Programme to advance novel cancer research
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
GSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention Programme
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
Irish Examiner11d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Professor Sarah Blagden, from the University of Oxford, will co-lead the new GSK-Oxford Cancer Immuno-Prevention Programme, which is backed by £50 million from GSK. She told BBC Radio 4’s Today ...